XML 114 R96.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Restricted Stock Award Activity) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Weighted Average Grant-Date Fair Value        
Allocated share-based compensation expense   $ 5.1    
Restricted stock awards        
Number of Award Shares        
Outstanding at the beginning of the period (in shares)   284,843 269,929  
Granted (in shares)   211,307 263,328  
Released (in shares)   (263,916) (247,814)  
Canceled (in shares)   (15,000) (600)  
Outstanding at the end of the period (in shares) 217,234 217,234 284,843 269,929
Weighted Average Grant-Date Fair Value        
Outstanding at the beginning of the period (in dollars per share)   $ 50.10 $ 49.49  
Granted (in dollars per share)   27.18 33.16  
Released (in dollars per share)   32.49 31.44  
Canceled (in dollars per share)   50.26 50.15  
Outstanding at the end of the period (in dollars per share) $ 49.19 $ 49.19 $ 50.10 $ 49.49
Allocated share-based compensation expense   $ 6.2 $ 8.7 $ 8.5
Time Based LTIP Awards        
Number of Award Shares        
Outstanding at the beginning of the period (in shares)   0    
Granted (in shares)   85,000    
Released (in shares)   0    
Canceled (in shares)   (15,000)    
Outstanding at the end of the period (in shares) 70,000 70,000 0  
Weighted Average Grant-Date Fair Value        
Outstanding at the beginning of the period (in dollars per share)     $ 0  
Granted (in dollars per share)   $ 48.16    
Released (in dollars per share)     $ 0  
Canceled (in dollars per share)   48.16    
Outstanding at the end of the period (in dollars per share) $ 48.16 $ 48.16   $ 0
Allocated share-based compensation expense   $ 2.5    
Performance-based restricted stock awards        
Number of Award Shares        
Outstanding at the beginning of the period (in shares)   1,537,000 1,492,000  
Granted (in shares)   245,000 523,000  
Released (in shares)   (488,500) (478,000)  
Canceled (in shares)   (131,500)    
Outstanding at the end of the period (in shares) 1,162,000 1,162,000 1,537,000 1,492,000
Weighted Average Grant-Date Fair Value        
Outstanding at the beginning of the period (in dollars per share)   $ 30.53 $ 29.36  
Granted (in dollars per share)   27.54 28.73  
Released (in dollars per share)   30.60 24.89  
Canceled (in dollars per share)   30.49    
Outstanding at the end of the period (in dollars per share) $ 29.88 $ 29.88 $ 30.53 $ 29.36
Allocated share-based compensation expense $ 2.9 $ 9.5 $ 15.6 $ 14.4